Analysed IMMUNOVANT INC (IMVT:NASDAQ) News Sources
Assessing Immunovant (IMVT) Valuation After Strong IMVT 1402 Phase 2 Rheumatoid Arthritis Trial Commentary
05-06-2026
yahoo.com
Immunovant to Report Financial Results for the First Quarter Ended June 30, 2026, and Provide Business Update on Thursday, August 6, 2026
23-07-2026
yahoo.com
Immunovant Provides Corporate Updates and Reports Financial Results for the Quarter Ended June 30, 2026
06-08-2026
yahoo.com
What is the current price of IMMUNOVANT INC (IMVT:NASDAQ)?
The current price of IMMUNOVANT INC (IMVT:NASDAQ) is $43.89.
IMMUNOVANT INC (IMVT:NASDAQ) absolute price change since previous trading day?
The absolute price change of IMMUNOVANT INC (IMVT:NASDAQ) since the previous trading day is $0.39.
IMMUNOVANT INC (IMVT:NASDAQ) percentage price change since previous trading day?
The percentage price change of IMMUNOVANT INC (IMVT:NASDAQ) since the previous trading day is 0.8966%.
What is the most recent average sentiment score for IMMUNOVANT INC (IMVT:NASDAQ)?
The most recent average sentiment score for IMMUNOVANT INC (IMVT:NASDAQ) is 63 out of 100.
What is the most recent average sentiment for IMMUNOVANT INC (IMVT:NASDAQ)?
The most recent sentiment for IMMUNOVANT INC (IMVT:NASDAQ) is .
SEC-8K** Filing Available For IMMUNOVANT INC (IMVT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.